Clinical Trial Update: A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial evaluating Colistimethate Sodium for Injection for treating carbapenem-resistant Gram-negative bacterial infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Gram-negative Bacterial Infection

Drugs mentioned

• Colistimethate Sodium for Injection (colistimethate sodium)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Mental Health Issue | Phase 3 | Status: UNKNOWN